These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12801861)

  • 1. Quantification of CD34 epitopes in AML.
    Sutherland R; Keeney M; Gratama JW
    Haematologica; 2003 Jun; 88(6):ELT22; author reply ELT23. PubMed ID: 12801861
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia.
    Maynadié M; Gerland L; Aho S; Girodon F; Bernier M; Brunet C; Campos L; Daliphard S; Deneys V; Falkenrodt A; Jacob MC; Kühlein E; LeCalvez G; Moskovtchenko P; Philip P; Carli PM; Faure GC; Béné MC;
    Haematologica; 2002 Aug; 87(8):795-803. PubMed ID: 12161354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping in acute leukaemia, myelodysplastic syndromes and hairy cell leukaemia. The use of monoclonal antibodies against myeloid differentiation antigens.
    Kristensen JS
    Dan Med Bull; 1994 Feb; 41(1):52-65. PubMed ID: 8187565
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
    Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
    Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A;
    Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
    van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The singular value of CD34 and CD117 expression for minimal residual disease detection in AML.
    Bahia Kerbauy DM; Kimura EY; Chauffaille ML; Bordin JO; Kerbauy J; Yamamoto M
    Leuk Res; 2003 Nov; 27(11):1069-70. PubMed ID: 12860002
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIRMA-K3, a new monoclonal antibody for CD34 immunophenotyping and stem and progenitor cell assay.
    Höffkes HG; Lowe JA; Pedersen RO; Schmidkte G; McDonald DF
    J Hematother; 1996 Jun; 5(3):261-70. PubMed ID: 8817393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia.
    Ngo N; Lampert IA; Naresh KN
    Br J Haematol; 2008 Feb; 140(3):279-86. PubMed ID: 17973948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34: structure, biology, and clinical utility.
    Krause DS; Fackler MJ; Civin CI; May WS
    Blood; 1996 Jan; 87(1):1-13. PubMed ID: 8547630
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.
    Venditti A; Del Poeta G; Maurillo L; Buccisano F; Del Principe MI; Mazzone C; Tamburini A; Cox C; Panetta P; Neri B; Ottaviani L; Amadori S
    Haematologica; 2004 Aug; 89(8):934-9. PubMed ID: 15339676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic peculiarities of mobilized stem (CD34+) cells in blood from patients with severe spinal cord injury.
    Tupitsyn NN; Yaryghin VN; Bryukhovetskiy AS; Grivtsova LY; Mentkevich GL; Dolgopolov IS; Zaitsev AY; Davydov MI
    J Biol Regul Homeost Agents; 2006; 20(1-2):36-40. PubMed ID: 18088553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia.
    Cheung AM; Chow HC; Liang R; Leung AY
    Br J Haematol; 2009 Feb; 144(4):484-91. PubMed ID: 19055666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.